Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients undergoing knee arthroscopy
3 findings from 1 review
no estimate extracted
7 studies · 297 participants
Low
no estimate extracted
7 studies · 297 participants
Low
no estimate extracted
7 studies · 297 participants
Low
Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
Morphine showed no clear difference in adverse eventsPercentage of participants with any adverse event compared with bupivacaine (moderate certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients undergoing knee arthroscopy
3 findings from 1 review
no estimate extracted
2 studies · 80 participants
Very low
no estimate extracted
2 studies · 80 participants
Low
no estimate extracted
2 studies · 80 participants
Low
Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · patients undergoing knee arthroscopy
1 finding from 1 review
Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
Morphine showed no clear difference in adverse eventsPercentage of participants with any adverse event compared with NSAIDs (moderate certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients undergoing knee arthroscopy
3 findings from 1 review
no estimate extracted
2 studies · 72 participants
Very low
no estimate extracted
2 studies · 72 participants
Low
no estimate extracted
1 study · 39 participants
Low
Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · patients undergoing knee arthroscopy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · patients undergoing knee arthroscopy
1 finding from 1 review
Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
Morphine showed no clear difference in adverse eventsPercentage of participants with any adverse event compared with placebo (low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients undergoing knee arthroscopy
3 findings from 1 review
no estimate extracted
5 studies · 248 participants
Low
no estimate extracted
6 studies · 330 participants
Low
no estimate extracted
5 studies · 270 participants
Low
Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · patients undergoing knee arthroscopy
1 finding from 1 review